Venture Valuation/Biotechgate and One Nucleus Partner to Boost Life Sciences Connectivity and Innovation

Zurich, Switzerland and Cambridge, UK, September 2023 – Biotechgate, a leading global life sciences business development and licensing database and One Nucleus, a Cambridge, UK-based life sciences and healthcare membership organisation, are thrilled to announce a collaboration to boost life sciences connectivity and innovation. The purpose of this collaboration is to provide a reliable hub … Continue reading Venture Valuation/Biotechgate and One Nucleus Partner to Boost Life Sciences Connectivity and Innovation

Read more

Norway Life Science Trend Analysis 2023

The Norwegian life sciences industry performed well in 2022 compared to the years before 2021 (2018 – 2020), raising USD 38 million in private equity investments according to Biotechgate data. However, it could not compete with the record level of venture financing in 2021 (USD 65 million). Cytovation ASA secured the largest round in 2022. … Continue reading Norway Life Science Trend Analysis 2023

Read more

The Top 5 Biggest Licensing Deals of 2023 So Far

As biotechs face a challenging commercial environment with limited options for IPOs, interest in forging partnership agreements remains high. This article explores five top biotech and pharma licensing deals, ranked by the potential total deal value, that 2023 has brought to date. From advancing precision oncology to regenerative medicine, these partnerships underscore a commitment to … Continue reading The Top 5 Biggest Licensing Deals of 2023 So Far

Read more

Biotech Product Valuation: Setting a Price for Acquisitions

Navigating the complex landscape of biotech valuations is often more of an art than a science. This article shows the methodologies and considerations implemented when assessing biotech products in a field where industry meets commerce. Big acquisitions like the purchase earlier in 2023 by Merck of Prometheus Biosciences are very good examples of how valuation … Continue reading Biotech Product Valuation: Setting a Price for Acquisitions

Read more

Venture Valuation/Biotechgate and AdvaMed Form Strategic Partnership to Drive MedTech Industry Growth

Media Release Zurich, Switzerland and Washington, D.C., USA, August 2023 – Biotechgate, a global business development and licensing database for the life sciences industry, is proud to announce its strategic partnership with the Advanced Medical Technology Association (AdvaMed). This collaboration aims to strengthen the data integration in Biotechgate, while enhancing the visibility and insight into … Continue reading Venture Valuation/Biotechgate and AdvaMed Form Strategic Partnership to Drive MedTech Industry Growth

Read more

Switzerland Life Science Trend Analysis 2023

Although shifts in the geopolitical landscape affected the Swiss life sciences industry in 2022, it resisted a major downturn in terms of private equity funding. Swiss biotech companies raised a total of USD 590 million in venture capital in 36 financing rounds. This is less than in the previous three years, but matches pre-COVID 19 … Continue reading Switzerland Life Science Trend Analysis 2023

Read more

How to Use Biotechgate for Your Business Development

With over 1.4 million total entries, the comprehensive Biotechgate Business Development Database serves as a vital tool for life science professionals worldwide in their organizations. In this article, you will find just some of the reasons that Biotechgate can enhance the business development activities of you and your colleagues. Market Exploration Containing over 65,000 individual … Continue reading How to Use Biotechgate for Your Business Development

Read more

Enhancing Market Exploration: A Client’s Success Story with Biotechgate

The Challenge: The client, a leading medical technology company, faced the challenge of identifying new biotech companies across multiple regions, including Benelux, and Scandinavia, and countries such as the UK, Ireland, Germany, Austria, and France. With time constraints and limited industry visibility, the client sought an efficient way to discover potential customers in the industry … Continue reading Enhancing Market Exploration: A Client’s Success Story with Biotechgate

Read more

Netherlands Life Science Trend Analysis 2023: A Difficult Year for Venture Financing

Tuesday, 04 July 2023 Biotechgate, the leading global biotech database, published their annual Trend Analysis Report 2023 of the Dutch life sciences sector. In 2022, compared to 2021, venture financing of life science and biotech companies went down by more than 50%. Furthermore, the year-to-year growth rate of new biotech ventures has been decreasing since 2018, with … Continue reading Netherlands Life Science Trend Analysis 2023: A Difficult Year for Venture Financing

Read more

Maryland Life Science Trend Analysis 2023

Maryland’s life science private equity investment landscape in 2022 shifted back to levels seen prior to the exceptional growth experienced in 2021. The total value of life science venture financing in Maryland dropped from USD 1.2 billion in 2021 to half that amount in 2022, with USD 558 million invested. Looking at the top venture … Continue reading Maryland Life Science Trend Analysis 2023

Read more